Studying Childhood-Onset Hemidystonia



Status:Completed
Conditions:Neurology, Orthopedic
Therapuetic Areas:Neurology, Orthopedics / Podiatry
Healthy:No
Age Range:7 - 40
Updated:12/26/2018
Start Date:September 10, 2011
End Date:December 20, 2018

Use our guide to learn which trials are right for you!

Characteristics and Mechanism of Childhood-Onset Hemidystonia

Background:

- Childhood-onset dystonia is caused by a brain injury. It causes muscle contractions and
twisting movements that the person with dystonia cannot control. The term hemidystonia is
used when only one side of the body is affected. When dystonia starts during childhood, the
brain and nerves may not develop normally. People with hemidystonia can become disabled
because of the unwanted postures and twisting that dystonia causes. More research is needed
to determine how dystonia affects brain development.

Objectives:

- To study brain function in people with hemidystonia.

Eligibility:

- Individuals between 18 and 40 years of age who developed hemidystonia before age 13.
Only one wrist may be affected by hemidystonia, and participants must have at least some
movement in that wrist.

- Healthy volunteers at least 18 years of age.

Design:

- This study requires five visits to the NIH Clinical Center: a screening visit and four
study visits. Each visit will last up to 3 hours. Visits will be scheduled about once a
week. The study procedures may be done in any order.

- Participants will be screened with a physical exam and medical history.

- Participants will have the following tests:

- Brain magnetic resonance imaging scan. During the scan, participants will be asked to
move their hand at the wrist when they hear a tone.

- Motor tests of arm movement, balance, and walking. These tests may also examine nerve
development and muscle tone.

- Two transcranial magnetic stimulation sessions to study the electrical activity of the
muscles and brain. These sessions may also involve sensory tests. Participants will have
hearing tests before the first session and after the second session.

- No treatment for hemidystonia will be provided as part of this study.

Objective

In childhood-onset hemidystonia, motor and sensory abnormalities pose a great challenge to
voluntary movement. In an effort to inform future methods of treatment of this disorder, this
study seeks to (1) characterize involuntary muscle activity, (2) explore neurophysiologic
mechanisms of involuntary muscle activity, (3) characterize abnormalities of sensation, (4)
assess performance on two sensorimotor tasks (voluntary postural control, and a
reach-to-grasp arm movement), and (5) explore brain abnormalities using imaging in
childhood-onset hemidystonia.

Study Population

The dystonia group will consist of 40 individuals (age 7-40 years) with childhood-onset
hemidystonia. The control group will consist of 40 individuals within the same age range with
no neurological disorders.

Design

This is a cross-sectional study, in which multiple assessments will be performed over a short
period. Results in the dystonia group will be compared to results in the control group. Due
to the laterality of brain injury in hemidystonia, outcomes from both arms and cortical
hemispheres will be compared to each other. Outcomes within the dystonia group will be
correlated with validated dystonia rating scales as well as with the age at the time of
injury.

Outcome Measures

In Objective 1, we will analyze the timing of involuntary electromyographic (EMG) activity
and kinematics triggered in the dystonic arm during various tasks. In Objective 2, we will
investigate various types of intracortical inhibition (short intracortical inhibition, long
intracortical inhibition, contralateral silent period, and ipsilateral silent period) and
intracortical facilitation in motor cortical regions controlling the dystonic wrist flexor
during voluntary contraction of the wrist extensor using transcranial magnetic stimulation
(TMS). In addition, we will perform a coherence analysis between EMG activity in the wrist
flexor and extensor muscles and between electroencephalographic (EEG) activity in the primary
motor cortex and the contralateral wrist muscles. In Objective 3, we will test tactile sense
(spatial and temporal), vibration sense, and stereognosis of the hand. In Objective 4, we
will analyze seated limits of stability (voluntary postural control), and the timing and
amplitude of EMG activity and kinematics in the arm during a reaching and grasping arm
movement. In Objective 5, we will obtain brain scans with structural magnetic resonance
imaging (MRI), diffusion tensor imaging (DTI), resting state functional connectivity MRI, and
functional MRI during a simple task.

- INCLUSION CRITERIA:

- Age 7 40 years, inclusive

- Good general health, with enough energy to carry out the assessments

- Ability to understand and comply with instructions. Adults must be able to provide
their own consent.

- Passive motion of at least 15 degrees extension and 15 degrees flexion from neutral of
both wrist joints

- Agreement to not drink caffeine or alcohol for 24 hours before each study session
because both agents can modify brain activity and may confound outcome measures.

Additional inclusion criteria for individuals with dystonia:

- Childhood-onset (before 13 years of age) hemidystonia in one wrist. Diagnosis of dystonia
will be made based on the Hypertonia Assessment Tool (HAT)

EXCLUSION CRITERIA:

Healthy Volunteers:

-Presence of any neurological disorders

Individuals with Dystonia:

- Botulinum toxin injection in the flexor carpi radialis and extensor carpi radialis in
the last 6 months

- Concurrent use of medicines for muscle tone (e.g., baclofen, trihexyphenedyl,
dantrolene sodium, tizanidine, or carbidopa/levodopa). If patients are taking these
medications daily, the treating physician will be contacted by the MAI to determine if
it is acceptable for the subject to temporarily discontinue the medication(s). If the
risk of weaning, or stopping the medication is deemed harmless, the MAI and/or
treating physician will determine a schedule to wean, or stop the medication. The goal
is for the subject to be off medication(s) for 24 hours prior to participating in
testing for this study. For these subjects, there will be at least 4 days between
scheduled research visits to avoid a prolonged time off medication(s).

Additional exclusion criteria for TMS:

- Seizure in the last 2 years

- Concurrent use of anti-seizure medication

- Hearing loss

- Cardiac pacemakers, implanted medication pumps, intracardiac lines, or acute, unstable
cardiac disease, with intracranial implants (e.g. aneurysm clips, shunts, stimulators,
cochlear implants, or electrodes) or any other metal object within or near the head,
excluding the mouth that cannot be safely removed.

Additional exclusion criteria for MRI:

- Inability to lie flat on the back for up to 1 hour

- Uncontrolled movements of the head when lying supine as determined by the MAI

- Discomfort being in small spaces for up to 1 hour

- Cardiac pacemakers, implanted medication pumps, intracardiac lines, or acute, unstable
cardiac disease, with intracranial implants (e.g. aneurysm clips, shunts, stimulators,
cochlear implants, or electrodes) or any other metal object within or near the head,
excluding the mouth that cannot be safely removed.

- Pregnancy: For any female of childbearing potential, a pregnancy test will be done.
Childbearing potential will be determined during the history and physical.
We found this trial at
1
site
9000 Rockville Pike
Bethesda, Maryland 20892
?
mi
from
Bethesda, MD
Click here to add this to my saved trials